GHRP-2 10mg
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue.
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue.
Browse nearby entries from the full catalog, starting with Purchase Peptides.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantGHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue. It binds to the ghrelin receptor (GHS-R1a) and activates Gq/PLC as well as calcium-mediated intracellular signaling pathways that regulate the release of growth hormone. GHRP-2 is widely used in research to investigate the regulation of the hypothalamic-pituitary axis, the pharmacology of endocrine receptors, and peptide-induced growth hormone release mechanisms.
GHRP-2 (also known as Pralmorelin) is a synthetic growth hormone secretagogue, known to bind to the ghrelin/growth hormone secretagogue receptor. It was the first of these growth hormone secretagogues to be introduced, and is currently marketed as a test peptide for assessing growth hormone deficiency and secondary adrenal insufficiency. GHRP-2 has been investigated in Phase II studies to assess dwarfism and is under active research regarding its effects on appetite, muscle growth, the immune system, and sleep cycles. GHRP-2 is active both orally and sublingually, so it does not need to be injected to exert its effects.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.